"There's enough behind ivermectin for COVID-19 that there must be something there"
This is a point that I find fascinating 
-
-
Indeed, if you remove just two trials from your analysis - Elgazzar and Niaee - there is not a single RCT that has found a benefit for mortality, and on aggregate the result is pretty solidly

Show this thread -
What then separates ivermectin from other repurposed drugs? Popularity?pic.twitter.com/aKSrYM3CfG
Show this thread -
Anyway, this doesn't mean that we should stop the ongoing large trials into ivermectin, but I do think it's an interesting point worth considering. Take away the fraud, rewind to the actual evidence, and what remains?
Show this thread -
What got me thinking about all of this is that we excluded lopinavir/ritonavir as a treatment based on not that much more null evidence than we now have for ivermectin. We need to finish the bigger trials, for many reasons, but still interesting
Show this thread
End of conversation
New conversation -
-
-
To be fair, and if I remember correctly, the Spanish trial had this mix-up of the doses, and the Latin American trial said they were underpowered. But it says something about the integrity of these trials that people actually admit that.
- End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.